The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …

The impact of estrogens and their receptors on immunity and inflammation during infection

AT Harding, NS Heaton - Cancers, 2022 - mdpi.com
Simple Summary Human health is significantly affected by microbial infections. One of the
largest determinants of the outcomes of such infections is the host immune response. Too …

Let's talk about sex characteristics—as a risk factor for invasive fungal diseases

M Egger, M Hoenigl, GR Thompson Iii, A Carvalho… - Mycoses, 2022 - Wiley Online Library
Biological sex, which comprises differences in host sex hormone homeostasis and immune
responses, can have a substantial impact on the epidemiology of infectious diseases …

Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study

D Garg, K Soundappan, R Agarwal, S Mukherjee… - Mycoses, 2023 - Wiley Online Library
Background Factors associated with pulmonary mucormycosis (PM) among subjects with
diabetes mellitus (DM) remain unclear. Following the coronavirus disease (COVID‐19) …

The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study

M Estakhr, Z Ghotbi, M Rostamihosseinkhani… - The Journal of Infection …, 2023 - jidc.org
Introduction: There have been some reports of the association between SARS-CoV-2
infection and mucormycosis. This study aims to compare the hospitalization rates and …

Experimental Models to Study the Pathogenesis and Treatment of Mucormycosis

R Ben-Ami - Journal of Fungi, 2024 - mdpi.com
Mucormycosis presents a formidable challenge to clinicians and researchers. Animal
models are an essential part of the effort to decipher the pathogenesis of mucormycosis and …

Antifungal activity of alexidine dihydrochloride in a novel diabetic mouse model of dermatophytosis

S Nabeela, A Date, AS Ibrahim… - Frontiers in Cellular and …, 2022 - frontiersin.org
Dermatophytosis is one of the most prevalent fungal infections and a major public health
problem worldwide. Recent years have seen a change in the epidemiological patterns of …

Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B

T Gebremariam, S Alkhazraji, Y Gu… - Antimicrobial agents …, 2024 - Am Soc Microbiol
ABSTRACT Ibrexafungerp (formerly SCY-078) is the first member of the triterpenoid class
that prevents the synthesis of the fungal cell wall polymer β-(1, 3)-D-glucan by inhibiting the …

Mouse models of mucormycosis

ID Jacobsen - Antifungal Immunity: Methods and Protocols, 2023 - Springer
Animal models have been crucial in understanding the pathogenesis and developing novel
therapeutic approaches for fungal infections in general. This is especially true for …

Emerging Threat: A Review on Mucormycosis as a Serious Health Challenge During the Pandemic

M Bhoyar, D Khobragade, G Daff, P Gujarkar… - …, 2025 - benthamdirect.com
During the COVID-19 pandemic, many critically ill patients undergoing intensive care or
ventilation developed a fungal infection known as Mucormycosis. This infection is primarily …